Literature DB >> 10500192

Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene.

T Zhang1, H Xiong, L X Kan, C K Zhang, X F Jiao, G Fu, Q H Zhang, L Lu, J H Tong, B W Gu, M Yu, J X Liu, J Licht, S Waxman, A Zelent, E Chen, S J Chen.   

Abstract

The promyelocytic leukemia zinc finger gene (PLZF) is involved in chromosomal translocation t(11;17) associated with acute promyelocytic leukemia. In this work, a 201-kilobase genomic DNA region containing the entire PLZF gene was sequenced. Repeated elements account for 19.83%, and no obvious coding information other than PLZF is present over this region. PLZF contains six exons and five introns, and the exon organization corresponds well with protein domains. There are at least four alternative splicings (AS-I, -II, -III, and -IV) within exon 1. AS-I could be detected in most tissues tested whereas AS-II, -III, and -IV were present in the stomach, testis, and heart, respectively. Although splicing donor and acceptor signals at exon-intron boundaries for AS-I and exons 1-6 were classical (gt-ag), AS-II, -III, and -IV had atypical splicing sites. These alternative splicings, nevertheless, maintained the ORF and may encode isoforms with absence of important functional domains. In mRNA species without AS-I, there is a relatively long 5' UTR of 6.0 kilobases. A TATA box and several transcription factor binding sites were found in the putative promoter region upstream of the transcription start site. PLZF is a well conserved gene from Caenorhabditis elegans to human. PLZF paralogous sequences are found in human genome. The presence of two MLL/PLZF-like alignments on human chromosome 11q23 and 19 suggests a syntenic replication during evolution. The chromosomal breakpoints and joining sites in the index acute promyelocytic leukemia case with t(11;17) also were characterized, which suggests the involvement of DNA damage-repair mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500192      PMCID: PMC18049          DOI: 10.1073/pnas.96.20.11422

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Direct DNA sequencing of PCR-amplified vector inserts following enzymatic degradation of primer and dNTPs.

Authors:  M Hanke; M Wink
Journal:  Biotechniques       Date:  1994-11       Impact factor: 1.993

3.  Ordered shotgun sequencing, a strategy for integrated mapping and sequencing of YAC clones.

Authors:  E Y Chen; D Schlessinger; J Kere
Journal:  Genomics       Date:  1993-09       Impact factor: 5.736

4.  Convenient single-step, one tube purification of PCR products for direct sequencing.

Authors:  E Werle; C Schneider; M Renner; M Völker; W Fiehn
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

5.  Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.

Authors:  G X Cheng; X H Zhu; X Q Men; L Wang; Q H Huang; X L Jin; S M Xiong; J Zhu; W M Guo; J Q Chen; S F Xu; E So; L C Chan; S Waxman; A Zelent; G Q Chen; S Dong; J X Liu; S J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.

Authors:  F Guidez; W Huang; J H Tong; C Dubois; N Balitrand; S Waxman; J L Michaux; P Martiat; L Degos; Z Chen
Journal:  Leukemia       Date:  1994-02       Impact factor: 11.528

7.  Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.

Authors:  S J Chen; A Zelent; J H Tong; H Q Yu; Z Y Wang; J Derré; R Berger; S Waxman; Z Chen
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).

Authors:  J D Licht; C Chomienne; A Goy; A Chen; A A Scott; D R Head; J L Michaux; Y Wu; A DeBlasio; W H Miller
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

9.  A method for constructing radiation hybrid maps of whole genomes.

Authors:  M A Walter; D J Spillett; P Thomas; J Weissenbach; P N Goodfellow
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

Authors:  Z Chen; N J Brand; A Chen; S J Chen; J H Tong; Z Y Wang; S Waxman; A Zelent
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  15 in total

1.  A gene located at 72A in Drosophila melanogaster encodes a novel zinc-finger protein that interacts with protein kinase CK2.

Authors:  M Kalive; R L Trott; A P Bidwai
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.

Authors:  Bai-Wei Gu; Hui Xiong; Yan Zhou; Bing Chen; Li Wang; Shuo Dong; Zhi-Yuan Yu; Ling-Feng Lu; Ming Zhong; Hai-Feng Yin; Gen-Feng Zhu; Wei Huang; Shuang-Xi Ren; Robert E Gallagher; Samuel Waxman; Guo-Qiang Chen; Zhu-Gang Wang; Zhu Chen; Gang Fu; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 3.  Analysis of phenotype-genotype connection: the story of dissecting disease pathogenesis in genomic era in China, and beyond.

Authors:  Yan Shen; Qi Xu; Zeguang Han; Han Liu; Guang-Biao Zhou
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

Review 4.  Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors.

Authors:  Joonsoo Kang; Nidhi Malhotra
Journal:  Annu Rev Immunol       Date:  2015-01-30       Impact factor: 28.527

5.  PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.

Authors:  Muhammad Wasim; Michela Carlet; Muhammad Mansha; Richard Greil; Christian Ploner; Alexander Trockenbacher; Johannes Rainer; Reinhard Kofler
Journal:  J Steroid Biochem Mol Biol       Date:  2010-05-06       Impact factor: 4.292

6.  Identification of promoter within the first intron of Plzf gene expressed in carp spermatogonial stem cells.

Authors:  Chinmayee Mohapatra; Hirak Kumar Barman
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

7.  C. elegans EOR-1/PLZF and EOR-2 positively regulate Ras and Wnt signaling and function redundantly with LIN-25 and the SUR-2 Mediator component.

Authors:  Robyn M Howard; Meera V Sundaram
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

8.  Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis.

Authors:  Francesco Piazza; José A Costoya; Taha Merghoub; Robin M Hobbs; Pier Paolo Pandolfi
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 9.  The emerging role of large immunophilin FK506 binding protein 51 in cancer.

Authors:  S Romano; A Sorrentino; A L Di Pace; G Nappo; C Mercogliano; M F Romano
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

10.  Dry-reagent disposable dipstick test for visual screening of seven leukemia-related chromosomal translocations.

Authors:  Despina P Kalogianni; Vasiliki Bravou; Theodore K Christopoulos; Penelope C Ioannou; Nicholas C Zoumbos
Journal:  Nucleic Acids Res       Date:  2007-01-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.